Diabetes may be an early manifestation of pancreatic cancer
A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type […]
A new study authored by scientists from the American Cancer Society, the Harvard T.H. Chan School of Public Health, the […] A drug discovered and advanced by The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) […] Mount Sinai researchers have identified a genetic biomarker of asthma that can be tested for using a simple nasal brush […] In a new study published June 7th, 2018 in PLOS Genetics, Christine Ambrosone of Roswell Park Comprehensive Cancer Center and […] A popular aquarium fish may hold answers to how tumors form in a childhood cancer. Muscle precursor cells called myoblasts […] Patient-derived organoids, hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond […] Our immune system’s arsenal of defenses usually protects us from cancer. But sometimes, cancer cells overwhelm or evade this elaborate […] In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved […] A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well […]Breast Cancer
Blood vitamin D levels linked to colorectal cancer risk
Drug targets metabolic vulnerability and impairs cancer cell growth and survival: Pre-clinical results for IACS-10759 drug leads to Phase I clinical trials in AML and solid tumors
Asthma diagnosed with nasal brush test: The team developed a biomarker of asthma using RNA sequencing and machine learning
Threat of malaria left its mark on the immune system in people with African ancestry: Researchers discover genetic difference between human groups that affects inflammation
Zebrafish expose tumor pathway in childhood muscle cancer
Organoid profiling identifies treatments for pancreatic cancer: They could be used to select the treatments most likely to work in specific patients
Two-pronged antibodies draw immune killers directly to cancer cells
New potential treatment option for triple negative breast cancer
Fewer men are being screened, diagnosed, and treated for prostate cancer